Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04772118 · ClinicalTrials.gov registry record · NA
Improving Cancer Outcomes Through Personalized Care Planning and Symptom Management.
A NA study, sponsored by Carevive Systems.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT04772118 is a NA study that has completed, run by Carevive Systems. The registered enrollment target is 51 participants.
The verdict
NCT04772118, a NA study, has completed, sponsored by Carevive Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
This Study is a case control Study conducted with 100 patients with a solid tumor cancer diagnosis (lung, breast, or gynecologic cancer). Records of 50 patients who received treatment plans as standard of care will be abstracted for control data. 50 patients undergoing cancer treatment will receive a treatment plan and report symptoms using Carevive PROmPT™.
Interventions
- OTHER Carevive PROmpt™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2021-02-16 |
| Est. Completion | 2021-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04772118
The ClinicalTrials.gov registry entry for NCT04772118 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carevive Systems, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Carevive PROmpt™ is the first listed.
NCT04772118 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04772118 about?
NCT04772118 is a clinical study titled "Improving Cancer Outcomes Through Personalized Care Planning and Symptom Management.". This Study is a case control Study conducted with 100 patients with a solid tumor cancer diagnosis (lung, breast, or gynecologic cancer). Records of 50 patients who received treatment plans as standard of care will be abstracted for control data. 50 patients undergoing cancer treatment will receive ...
What is the current status of trial NCT04772118?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2021-02-16. Estimated completion is 2021-11-01.
What interventions are being tested in trial NCT04772118?
The interventions under investigation include: Carevive PROmpt™ (OTHER).
Who is sponsoring clinical trial NCT04772118?
This trial is sponsored by Carevive Systems, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.